Novo Nordisk A/S logo

Novo Nordisk A/S

NONOF | OTC
Chart Builder DCF Calculator
$39.22
-$0.70 (-1.75%)
Sep 22, 2026, 10:38 AM ET · Market open
Fiscal Year
Period Ending
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
FY 2019
Dec 30, 2019
Cash & Equivalents
15.66B 14.39B 12.65B 10.72B 12.76B 15.48B
Short-Term Investments
10.65B 15.84B 10.92B 6.77B n/a n/a
Long-Term Investments
2.68B 1.66B 1.34B 1.44B 1.65B 1.81B
Other Long-Term Assets
4.02B 1.43B 206M 267M 674M 841M
Receivables
87.41B 75.26B 57.51B 46.8B 32.18B 29.15B
Inventory
40.85B 31.81B 24.39B 19.62B 18.54B 17.64B
Other Current Assets
6.33B 2.34B 2.73B 7.85B 6.78B 4.43B
Total Current Assets
160.9B 139.65B 108.19B 85.6B 65.81B 62.46B
Property-Plant & Equipment
162.49B 90.96B 66.67B 55.36B 50.27B 50.55B
Goodwill & Intangibles
111.09B 60.41B 50.94B 43.17B 20.66B 5.84B
Total Long-Term Assets
304.9B 174.84B 133.06B 108.91B 79.11B 63.16B
Total Assets
465.8B 314.49B 241.26B 194.51B 144.92B 125.61B
Account Payables
28.85B 25.61B 15.59B 8.87B 5.72B 6.36B
Deferred Revenue
n/a n/a n/a 55.18B 38.73B 35.33B
Short-Term Debt
11.78B 5.3B 480M 12.86B 6.68B 659M
Other Current Liabilities
165.85B 38.14B 103.89B 21.78B 18.37B 15.82B
Total Current Liabilities
217.53B 169.66B 120.94B 99.52B 70.27B 58.98B
Long-Term Debt
84.25B 15.98B 20.78B 9.65B n/a n/a
Other Long-Term Liabilities
9.68B 7.58B 5.45B 360M 5.93B 5.95B
Total Long-Term Liabilities
104.78B 38.27B 36.83B 24.25B 11.32B 9.04B
Total Liabilities
322.31B 207.93B 157.77B 123.76B 81.6B 68.02B
Total Debt
102.79B 27.01B 25.78B 26.65B 10.36B 4.48B
Book Value
143.49B 106.56B 83.49B 70.75B 63.33B 57.59B
Book Value Per Share
32.17 23.71 18.37 15.36 13.53 12.11
Common Stock
446M 451M 456M 462M 470M 480M
Retained Earnings
144.45B 104.84B 80.59B 72B 63.77B 57.82B
Comprehensive Income
-1.41B 1.28B 2.45B -1.71B -911M -694M
Shareholders Equity
143.49B 106.56B 83.49B 70.75B 63.33B 57.59B
Total Investments
13.33B 17.5B 12.26B 8.21B 1.65B 1.81B

© 2026 bestshares.com. All rights reserved.